Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Cheerios Warning Signals Tougher Stance On Health Claims Enforcement

This article was originally published in The Tan Sheet

Executive Summary

FDA's warning letter to General Mills concerning cardiovascular health claims linked to Cheerios reflects a newly empowered agency and foreshadows aggressive regulatory activity to come, experts say

You may also be interested in...



Claims Emerge To Join “Natural” As Class Action Fodder

Claims a product is “natural,” health and prevention claims, “whole grain” and “made with” claims, all can put a firm at risk for a lawsuit, the Center for Science in the Public Interest warns. After climbing for five years in a row, class action lawsuits brought against food products dipped in 2013, but the decline may be short-lived.

Claims Emerge To Join “Natural” As Class Action Fodder

Claims a product is “natural,” health and prevention claims, “whole grain” and “made with” claims, all can put a firm at risk for a lawsuit, the Center for Science in the Public Interest warns. After climbing for five years in a row, class action lawsuits brought against food products dipped in 2013, but the decline may be short-lived.

ConAgra’s Petition For Whole Grain/Diabetes Claim Draws Opposition

Kellogg Co. disagrees with ConAgra’s petition to FDA for a qualified health claim linking whole grain consumption with reduced risk of type 2 diabetes. Other experts question ConAgra’s supporting evidence and maintain fiber content should be emphasized over whole grains in product labeling.

Related Content

Topics

UsernamePublicRestriction

Register

ID1130765

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel